Accueil>>Signaling Pathways>> Apoptosis>> Bcl-2 Family>>S55746 hydrochloride (BLC201 (hydrochloride))

S55746 hydrochloride (BLC201 (hydrochloride)) (Synonyms: BCL201 hydrochloride)

Catalog No.GC33401

Le chlorhydrate de S55746 (BLC201 (chlorhydrate)) (chlorhydrate de BCL201) est un inhibiteur de BCL-2 puissant, actif par voie orale et sélectif, avec un Ki de 1,3 nM et un Kd de 3,9 nM. Le chlorhydrate de S55746 (BLC201 (chlorhydrate)) (chlorhydrate de BCL201) a une activité antitumorale avec une faible toxicité.

Products are for research use only. Not for human use. We do not sell to patients.

S55746 hydrochloride (BLC201 (hydrochloride)) Chemical Structure

Cas No.: 1448525-91-4

Taille Prix Stock Qté
5mg
115,00 $US
En stock
10mg
202,00 $US
En stock
25mg
414,00 $US
En stock
50mg
745,00 $US
En stock
100mg
1 379,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

S55746 hydrochloride is a potent, orally active and selective BCL-2 inhibitor, with Kis and Kds of 1.3 nM, 520 nM and 3.9 nM, 186 nM for BCL-2 and BCL-XL, respectively. S55746 hydrochloride has antitumor activity.

S55746 hydrochloride is a potent, orally active and selective BCL-2 inhibitor, with Kis and Kds of 1.3 nM, 520 nM and 3.9 nM, 186 nM for BCL-2 and BCL-XL, respectively. S55746 selectively induces cell death. S55746 potently causes RS4;11 cell killing with an IC50 of 71.6 nM after 72 h of treatment, but shows a much weaker activity in H146 (IC50 1.7 μM), a BCL-XL-dependent cell line. S55746 also selectively induces apoptosis through BCL-2 inhibition in a BAX/BAK-dependent manner. S55746 (3 nM) induces cell death in CLL cells[1].

S55746 is a highly efficacious and well-tolerated orally active BCL-2 inhibitor. S55746 (25 and 100 mg/kg, p.o.) inhibits xenograft growth in RS4;11 and Toledo models[1].

[1]. Casara P, et al. S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth. Oncotarget. 2018 Apr 13;9(28):20075-20088.

Avis

Review for S55746 hydrochloride (BLC201 (hydrochloride))

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for S55746 hydrochloride (BLC201 (hydrochloride))

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.